20 20 Biolabs Inc (AIDX) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 |
|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 47.96%0.38 | 0.73 | 0.35 |
| Cost Of Revenue | 33.46%0.28 | 0.43 | 0.29 |
| Gross Profit | 68.21%0.10 | 0.30 | 0.06 |
4.01%1.49 | 1.55 | 1.51 | |
| Selling, General, and Administrative | 5.58%1.36 | 1.29 | 1.35 |
| Research and Development | 52.11%0.12 | 0.26 | 0.15 |
| Operating Income/Loss | 11.71%-1.39 | -1.24 | -1.44 |
| Nonoperating Income/Loss | 105.65%0.01 | -0.26 | -0.73 |
8.71%-1.38 | -1.51 | -2.17 | |
| Attributable To Parent | 8.71%-1.38 | -1.51 | -2.17 |
| Available To Common Stockholders, Basic | 45.38%-1.50 | -2.75 | -2.12 |
| Preferred Stock Dividends And Other Adjustments | 5.57%0.13 | 0.12 | -0.05 |
| Basic Average Shares | 20.09%12.96 | 10.79 | 7.66 |
| Diluted Average Shares | 20.09%12.96 | 10.79 | 7.66 |
| Basic Earnings Per Share | 53.85%-0.12 | -0.26 | -0.28 |
| Diluted Earnings Per Share | 53.85%-0.12 | -0.26 | -0.28 |